Selank vs Semax
Two short synthetic peptides referenced in nootropic-research literature — what they share, where they diverge.
Common origins
Selank and Semax are both short synthetic peptides developed in Russian research programmes and referenced in nootropic-research literature. They share design heritage in the use of short, stabilised amino-acid sequences with central-nervous-system relevance.
Where they diverge
The two compounds differ in sequence, receptor engagement, and the research contexts in which they're commonly examined. Selank is more often referenced in anxiolytic and immunomodulatory research; Semax is more often referenced in neuroprotection and cognitive contexts.